Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02918162
Title Perioperative Chemo and Pembrolizumab in Gastric Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Paul Oberstein

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma


Capecitabine + Epirubicin + Oxaliplatin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.